• Medical_Professionals
• Medical_students
• Nurses

At the end of each presentation, the participant will be able to:

Suspecting Pituitary Disorders "What's Next?"

Ji Hyun (CJ) Chun, MPAS, PA-C

1.Describe medically relevant anatomy and physiology of the pituitary gland.

2.Outline appropriate evaluation of pituitary adenomas and function. 

3.Describe common functional pituitary adenomas (prolactinoma, acromegaly).

4.Acknowledge signs and symptoms of hypopituitarism.

Adrenal Insufficiency and Cushing’s

B. Scott Urquhart, PA-C, DFAAPA

1.Analyze etiologies, clinical presentation, work-up, and management of primary adrenal insufficiency.

2.Investigate the clinical presentation, work-up, and treatment of hypercortisolemia as it relates to Cushing’s syndrome / disease.

Adrenal Disease: Pheochromocytoma and Adrenal Adenomas

B. Scott Urquhart, PA-C, DFAAPA

1.Examine the presentation of pheochromocytoma and implement a simple work-up for the diagnosis and proper referral.

2.Explore incidentally discovered adrenal adenomas with respect to initial discovery, imaging, work-up, treatment, and follow-up.

Dyslipidemia: 'The Changing Paradigm'

Joyce Ross, MSN, RNC, CPNP, CS, FNLA

1.Understand commonalties and differences found within the ACC/AHA guidelines and the National Lipid Association Recommendations for management of dyslipidemia.

2.Discuss the role of the CYP 450 metabolic pathway in medication management.

3.Indicate appropriate application of medication in the treatment of dyslipidemia. 

Obesity: The Latest Skinny on Fat

Christine Kessler, MN, CNS, ANP, BC-ADM, CDTC, FAANP

1.Review the latest epidemiologic factors likely influencing the rise of obesity in this country.

2.Describe various interconnections between fat (and selected adipokines), gut incretins and neuropeptides in relation to satiety, calorie utilization, addictions and mood.

3.Correlate selected obesity co-morbidities to abnormal adipokine release and enteroendocrine function.

4.Relate the physiologic impact of various behavioral, pharmacologic, and surgical intervention strategies in obesity prevention and treatment.

5.Review the efficacy of common over-the-counter weight loss remedies.

Diabetic Autonomic Neuropathies and Retinopathy

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC

1.Describe the microvascular complications of retinopathy and autonomic neuropathy that affect patients suffering from diabetes mellitus.

2.Identify the clinical manifestations of these complications.

3.Apply current screening recommendations to ensure patients receive timely care.

Vascular Risk: What's Really Important?

Joyce Ross, MSN, RNC, CPNP, CS, FNLA

1.Recall the relationship of elevated glucose to cardiovascular disease (CVD).

2.State how inflammatory risk factors are contributory to CVD.

3.Discuss lipid target stratification in those with elevated glucose levels or DM.

4.Articulate the role of hypertension to increased CVD.

5.Explain pro-thrombotic status related to elevated glucose or DM.

Case Studies in Type 2 Diabetes: Which Agents and Why

Lucia M. Novak, MSN, ANP-BC, BC-ADM, CDTC 

B. Scott Urquhart, PA-C, DFAAPA

1.Review the current ADA/EASD, and AACE guidelines for pharmacologic management of diabetes.

2.Critique the pharmacologic options with their expected A1c reductions, side effect profiles and safety concerns.

3.Apply a glucose-centric approach to incorporate oral and non-insulin injectable agents in the treatment of patients with type 2 diabetes.

4.Demonstrate how a patient-centric approach promotes empowerment and positive outcomes.

Insulin Overview: What’s on the Menu? Tackling the Differences

Holly Jodon, MPAS, PA-C, DFAAPA

1.Distinguish a variety of insulin options available to treat people with diabetes. 

2.Verbalize the differences in pharmacokinetic profiles of human insulin and insulin analogs including U-100 vs U-300 glargine insulin.

3.Identify insulin available in vials and insulin pens.

4.Effectively write a prescription for insulin.

USD

Group registrations not allowed

Accompanying persons not allowed

We don’t accept Online Abstracts

JW Marriott Scottsdale Camelback Inn

5402 East Lincoln Drive

Scottsdale, Arizona, 85253

Relax and enjoy a luxurious retreat amidst the splendor of the Sonoran Desert for just $109 a night for MEDS participants. (Rate applies up to 3 days prior and after the conference- so extend your stay!) To make your reservation call the JW Marriott reservation department at 888-236-2427 or 800-582-2169 and mention you are a MEDS attendee or click here to make your reservation online

Submission Info

Kathleen Wenzler , Conference Marketing Director , Global Academy for Medical Education, LLC

Phone: 973-206-8092

Fax: 201-822-6114

Email: k.wenzler@globalacademycme.com

Kathleen Wenzler , Conference Marketing Director , Global Academy for Medical Education, LLC

Phone: 973-206-8092

Fax: 201-822-6114

Email: k.wenzler@globalacademycme.com